Quant Biomarkers

The AI engine Fit Assessment

Beta

Quant Biomarkers leverages machine learning for pattern discovery and therapeutic target identification, focusing on personalized biomarker development.

Blurb

Operator of a biotechnology research firm intended to focus on the development and application of quantitative biomarkers.

HQ Location

Basel (Switzerland)

Founded

2021

Employees

1 - 10

Total funding raised

Not available

Funding Status

Not available
Subspaces
  • Biomarker Identification

Operator of a biotechnology research firm intended to focus on the development and application of quantitative biomarkers. The company uses a combination of artificial intelligence, machine learning and advanced biological science to analyze large datasets of clinical data and identify patterns that can be used to predict health outcomes and identify potential therapeutic targets, enabling people to live longer, healthier lives by identifying and addressing potential health risks.